WAVEMAN · COMPANY
SNYRQ · Synergy Chc Corp.
> Ask across nine datasets ⌘K
LIVE
TEAM-1.27% 13F +439META+4.50% 13F +2,704RCG-0.33% CLUSTERUTHR-3.52% 13F +427CRWV+3.72% 13F +694CRM+0.27% 13F +1,024CVNA+0.36% 13F +799DELL-2.51% 13F +1,208TPL+0.75% 13F +443NET+1.84% 13F +713MSTR-0.36% 13F +525CRWD-1.07% 13F +1,384ANET+1.10% 13F +1,327COIN+0.55% 13F +475TEAM-1.27% 13F +439META+4.50% 13F +2,704RCG-0.33% CLUSTERUTHR-3.52% 13F +427CRWV+3.72% 13F +694CRM+0.27% 13F +1,024CVNA+0.36% 13F +799DELL-2.51% 13F +1,208TPL+0.75% 13F +443NET+1.84% 13F +713MSTR-0.36% 13F +525CRWD-1.07% 13F +1,384ANET+1.10% 13F +1,327COIN+0.55% 13F +475
← ALL COMPANIES

SNYRQ

Synergy CHC Corp.
PHARMA & BIOTECH · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · CIK 0001562733
SEC FILINGS☆ WATCH
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
11
13F, latest reported quarter

WaveMan Stock Sonar 1/7 axesFind similar shapesCompare

Institutional and government
20
inputs
  • Funds adding, latest quarter11 · 20 pct, sector of 698
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
6 not measured: Profitability, Financial health, Growth, Insider conviction, Risk and compliance, US patents
  • Profitability needs 2 of 4 inputs, 0 present: not filed
  • Financial health needs 1 of 2 inputs, 0 present: not filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Insider conviction needs 1 of 2 inputs, 0 present: no insider trades in 180 days; no open-market insider trades in 180 days
  • Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

1 of 7 axes scored, each a percentile against sector peers (universe where the sector is thin). Higher is better on every axis; an unscored axis is unmeasured, not a low score. How it is scored

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
11 funds added or opened last quarter
below 80% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
no short interest reported

Watch SNYRQ

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

Email me when insiders trade SNYRQ
Live price
Daily candles from TradingView, on their licence , no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows 11 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLINSM
Insider transactions
Form 4 purchases and sales (codes P and S), grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for Synergy CHC Corp. in the period covered. Source: SEC Form 4 filings, as of 2026-09-25.

INSIDER
FILED
SHARES
VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to use the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
JANE STREET GROUP, LLC
181,648 sh
$36.1K
ACT Advisors, LLC.
151,840 sh
$30.1K
XTX Topco Ltd
61,270 sh
$12.2K
VANGUARD CAPITAL MANAGEMENT LLC
38,909 sh
$7.7K
GEODE CAPITAL MANAGEMENT, LLC
32,775 sh
$6.5K
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.